How to Buy Indrayani Biotech Ltd Shares?
You can easily buy the stocks/shares of Indrayani Biotech Ltd (INDRANIB) on Tickertape or through broker platform by opening a Demat & Trading account onlineWhat is the Share Price of Indrayani Biotech Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of INDRANIB as on 15th May 2025 is ₹25.57What is the return on Indrayani Biotech Ltd share?
The past returns of Indrayani Biotech Ltd (INDRANIB) share are- Past 1 week: N/A
- Past 1 month: -99.60
- Past 3 months: -19.24
- Past 6 months: -58.08
- Past 1 year: -69.24
- Past 3 years: -61.38
- Past 5 years: 91.93
What is the Dividend yield % on Indrayani Biotech Ltd share?
The current dividend yield of Indrayani Biotech Ltd (INDRANIB) is N/AWhat is the Market Cap of Indrayani Biotech Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Indrayani Biotech Ltd (INDRANIB) is ₹70.26Cr as of 15th May 2025What is the 52 Week High and Low of Indrayani Biotech Ltd?
The 52-week high and low of Indrayani Biotech Ltd (INDRANIB) is ₹62.71 and ₹14.05.What is the PE and PB ratio of Indrayani Biotech Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Indrayani Biotech Ltd are 48.12 and 0.92 respectively.Which sector does Indrayani Biotech Ltd belong to?
Indrayani Biotech Ltd (INDRANIB) belongs to the Information Technology sector & Software Services sub-sector.What are the peers or stocks similar to Indrayani Biotech Ltd?
The peers or stocks similar to Indrayani Biotech Ltd are: and many others.Can't decide whether or not to buy Indrayani Biotech Ltd?
Worry no more! Login to Tickertape and check out Indrayani Biotech Ltd (INDRANIB) scorecard & all the relevant insights today5. Test Stocks FAQ What is the 52 Week High and Low of Indrayani Biotech Ltd?
The 52-week high and low of Indrayani Biotech Ltd (INDRANIB) is ₹62.71 and ₹14.05.1. Test Stocks FAQ for Indrayani Biotech Ltd Shares?
You can easily buy the stocks/shares of Indrayani Biotech Ltd (INDRANIB) on Tickertape or through broker platform by opening a Google & Trading account online3. Test Stocks FAQ What is the Share Price of Indrayani Biotech Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of INDRANIB as on 15th May 2025 is ₹25.57
Indrayani Biotech Ltd
INDRANIB Share Price
25.5768.67% (+10.41)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
INDRANIB Performance & Key Metrics
INDRANIB Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 48.46 | 0.92 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 29.08 | 8.05 | 2.34% |
INDRANIB Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
INDRANIB Company Profile
Indrayani Biotech is engaged in providing travel technology and solutions.
PERSISTENT
PE Ratio
65.08
65.08
1Y Return
55.18%
55.18%
Buy Reco %
55.56
55.56
PE Ratio
34.57
34.57
1Y Return
1.86%
1.86%
Buy Reco %
100.00
100.00
PE Ratio
37.15
37.15
1Y Return
9.36%
9.36%
Buy Reco %
24.00
24.00
TATAELXSI
PE Ratio
50.66
50.66
1Y Return
11.60%
11.60%
Buy Reco %
14.29
14.29
INTELLECT
PE Ratio
49.54
49.54
1Y Return
11.56%
11.56%
Buy Reco %
40.00
40.00
INDRANIB Sentiment Analysis
INDRANIB Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
INDRANIB Stock Summary · January 2025
Company is navigating a complex landscape characterized by declining market share in deposits, challenges in meeting Priority Sector Lending (PSL) obligations, and fluctuations in current account flows. Despite these hurdles, the bank is focusing on enhancing customer engagement and service delivery to drive deposit growth, with recent monthly inflows showing a positive trend. The management emphasizes a strategic approach to maintaining profitability over aggressive expansion, particularly in light of competitive pressures and a tight liquidity environment. Efforts to improve operational efficiencies through digitization and a commitment to stable cost management are underway, alongside a proactive strategy to reduce borrowings and strengthen the balance sheet. Overall, while facing short-term challenges, the bank remains optimistic about future performance and is committed to achieving sustainable growth through strategic investments and improved customer outreach.
INDRANIB Stock Growth Drivers
INDRANIB Stock Growth Drivers
2Focus on Sustainable Growth
Company is prioritizing profitable growth over mere expansion, emphasizing a strategy that encourages ground-level teams
Stable Financial Metrics
The company has maintained a return on assets (ROA) of 1.9% post-merger, showcasing stability in
INDRANIB Stock Challenges
INDRANIB Stock Challenges
3Deposit Growth Shortfalls
The company has experienced deposit growth that has not met expectations, attributed to seasonal trends
Loan Growth Concerns
There is uncertainty regarding the company's loan deposit ratio (LDR) and its implications for loan
INDRANIB Forecast
What are forecasts?
What are forecasts?
Forecasting uses historical data as inputs to make informed predictive estimates determining the direction of future trends. Price, revenue & earnings forecasts represent where the stock level, business prospects and profits are potentially expected to be at the end of the forecast period
INDRANIB Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
INDRANIB
INDRANIB
Income
Balance Sheet
Cash Flow
Annual Normal View
INDRANIB Income Statement
INDRANIB Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.16 | 50.10 | 21.36 | 61.79 | 167.42 | 167.44 | 41.29 | 41.29 | ||||||||||
Raw Materials | 0.10 | 0.12 | 0.22 | 32.48 | 15.77 | 41.04 | 102.21 | 97.13 | 32.29 | 32.30 | ||||||||||
| Power & Fuel Cost | 0.48 | 0.33 | 0.34 | 6.08 | 6.70 | |||||||||||||||
| Employee Cost | 10.81 | 5.39 | 9.58 | 23.01 | 23.07 | |||||||||||||||
| Selling & Administrative Expenses | 2.09 | 3.60 | 2.69 | 7.77 | 6.73 | |||||||||||||||
| Operating & Other expenses | 1.26 | 5.05 | 1.15 | 7.04 | 8.94 | |||||||||||||||
EBITDA | -0.10 | -0.12 | -0.06 | 2.98 | -8.78 | 6.99 | 21.31 | 24.87 | 9.00 | 8.99 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 1.01 | 0.46 | 0.66 | 3.35 | 3.80 | 1.02 | 1.02 | ||||||||||
| PBIT | -0.10 | -0.12 | -0.06 | 1.97 | -9.24 | 6.33 | 17.96 | 21.07 | 7.98 | 7.97 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 1.15 | 1.97 | 1.89 | 5.64 | 10.10 | 7.32 | 7.32 | ||||||||||
| PBT | -0.10 | -0.12 | -0.06 | 0.82 | -11.21 | 4.44 | 12.32 | 10.97 | 0.66 | 0.65 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.56 | 4.61 | -0.80 | -0.80 | ||||||||||
| Net Income | -0.10 | -0.12 | -0.06 | 0.82 | -11.21 | 4.44 | 8.76 | 6.36 | 1.46 | 1.45 | ||||||||||
| EPS | -0.29 | -0.34 | -0.15 | 2.25 | -5.92 | 1.30 | 2.56 | 1.59 | 0.32 | 0.32 | ||||||||||
| DPS | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
INDRANIB Company Updates
INDRANIB Stock Peers
What are peers and why compare against them?
What are peers and why compare against them?
A stock's peers are companies which have similar business interests, operations and belong to the same industry sector. Comparing various metrics against peers can give valuable insights on whether the company's stock is over/under-valued and the company's growth outlook vs the industry as a whole
INDRANIB Past Performance & Peer Comparison
INDRANIB Past Performance & Peer Comparison
Comparing 3 stocks from
Information TechnologySoftware Services
Compare valuation-basic on Screener
Information TechnologySoftware Services
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Indrayani Biotech Ltd | 48.12 | 0.92 | — |
| Persistent Systems Ltd | 65.08 | 18.38 | 0.59% |
| Oracle Financial Services Software Ltd | 34.57 | 10.47 | 2.79% |
| L&T Technology Services Ltd | 37.15 | 7.72 | 1.24% |
INDRANIB Stock Price Comparison
Compare INDRANIB with any stock or ETFCompare INDRANIB with any stock or ETF
INDRANIB
INDRANIB Holdings
INDRANIB Shareholdings
What are shareholdings?
What are shareholdings?
Apart from retail investors, a company’s shares are held by promoters, foreign & domestic institutions (large investors) and mutual funds. Promoters are the ship captains and control the company’s direction. Along with institutional and mutual fund holdings, a change in their holdings can indicate performance outlook for the stock
INDRANIB Promoter Holdings Trend
INDRANIB Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
INDRANIB Institutional Holdings Trend
INDRANIB Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
INDRANIB Shareholding Pattern
INDRANIB Shareholding Pattern
INDRANIB Shareholding History
INDRANIB Shareholding History
Foreign Institutions
smallcases containing INDRANIB stock
smallcases containing INDRANIB stock
Looks like this stock is not in any smallcase yet.
INDRANIB Events
INDRANIB Events
INDRANIB Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
INDRANIB has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
INDRANIB Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
INDRANIB has not given any dividends in last 5 years
INDRANIB Dividends
INDRANIB Dividends
Hmm, looks like data is unavailable here. Please come back after some timeINDRANIB Stock News & Opinions
INDRANIB Stock News & Opinions
Articles & Videos
Earnings
Indrayani Biotech standalone net profit rises 1485.71% in the March 2025 quarter
Net profit of Indrayani Biotech rose 1485.71% to Rs 1.11 crore in the quarter ended March 2025 as against Rs 0.07 crore during the previous quarter ended March 2024. Sales declined 41.27% to Rs 9.28 crore in the quarter ended March 2025 as against Rs 15.80 crore during the previous quarter ended March 2024. For the full year,net profit declined 0.68% to Rs 1.45 crore in the year ended March 2025 as against Rs 1.46 crore during the previous year ended March 2024. Sales declined 39.39% to Rs 37.77 crore in the year ended March 2025 as against Rs 62.32 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales9.2815.80 -41 37.7762.32 -39 OPM %18.536.27 -14.489.10 - PBDT0.261.97 -87 1.674.46 -63 PBT0.201.62 -88 0.653.01 -78 NP1.110.07 1486 1.451.46 -1 Powered by Capital Market - Live
5 days agoCapital Market - Live
Corporate
Indrayani Biotech adjourns board meeting
Indrayani Biotech has adjourned the meeting of the Board of Directors which was scheduled to be held on 9 June 2025. The meeting will now be held on 12 June 2025.Powered by Capital Market - Live
1 week agoCapital Market - Live
Corporate
Indrayani Biotech to discuss results
Indrayani Biotech will hold a meeting of the Board of Directors of the Company on 9 June 2025.Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Corporate
Indrayani Biotech to consider right Issue
Indrayani Biotech will hold a meeting of the Board of Directors of the Company on 3 April 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Indrayani Biotech consolidated net profit declines 75.51% in the December 2024 quarter
Net profit of Indrayani Biotech declined 75.51% to Rs 0.24 crore in the quarter ended December 2024 as against Rs 0.98 crore during the previous quarter ended December 2023. Sales declined 55.69% to Rs 17.32 crore in the quarter ended December 2024 as against Rs 39.09 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales17.3239.09 -56 OPM %16.868.80 - PBDT1.892.12 -11 PBT0.431.08 -60 NP0.240.98 -76 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Indrayani Biotech to discuss results
Indrayani Biotech will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Indrayani Biotech consolidated net profit declines 77.98% in the September 2024 quarter
Net profit of Indrayani Biotech declined 77.98% to Rs 1.22 crore in the quarter ended September 2024 as against Rs 5.54 crore during the previous quarter ended September 2023. Sales declined 23.81% to Rs 30.81 crore in the quarter ended September 2024 as against Rs 40.44 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales30.8140.44 -24 OPM %16.5918.05 - PBDT3.996.45 -38 PBT1.205.54 -78 NP1.225.54 -78 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Indrayani Biotech to table results
Indrayani Biotech will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Indrayani Biotech announces board meeting date
Indrayani Biotech will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Indrayani Biotech AGM scheduled
Indrayani Biotech announced that the 32nd Annual General Meeting(AGM) of the company will be held on 22 August 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 301.74%, vs industry avg of 14.26%
Over the last 5 years, market share increased from 0% to 0.26%